On this page:OverviewFunded papers
ScholarIQanswers from OpenAlex

Mallinckrodt Pharmaceuticals

FunderResearch funding and supported work

Mallinckrodt Pharmaceuticals is a funder indexed in ScholarIQ from OpenAlex.

What is known about Mallinckrodt Pharmaceuticals?

ScholarIQrecord summary

American-Irish domiciled manufacturer of specialty pharmaceuticals

How many works does Mallinckrodt Pharmaceuticals have?

ScholarIQindexed works

Mallinckrodt Pharmaceuticals has 621 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.

What is the OpenAlex record for Mallinckrodt Pharmaceuticals?

ScholarIQopenalex

The OpenAlex for Mallinckrodt Pharmaceuticals is on the source record.

What are the most-cited papers on Mallinckrodt Pharmaceuticals?

ScholarIQmost cited works
Immunoglobulin A Nephropathy: Advances in Understanding of Pathogenesis and Treatment
Richard Lafayette, Ellie Kelepouris
American Journal of Nephrology. 201833 CitationsOPEN ACCESS
<p>Treatment Patterns and Health Care Costs of Lupus Nephritis in a United States Payer Population</p>
Laura Bartels-Peculis, Ajay Sharma, Alison Edwards, Anirudh Sanyal, Erin Connolly-Strong, Winnie W. Nelson
Open Access Rheumatology Research and Reviews. 202018 CitationsOPEN ACCESS
Patients with Idiopathic Membranous Nephropathy: A Real-World Clinical and Economic Analysis of U.S. Claims Data
Tara Nazareth, Furaha Kariburyo, Aaron Kirkemo, Lin Xie, Anna Pavlova-Wolf, Laura Bartels-Peculis, Neel Vaidya, John J. Sim
Journal of Managed Care & Specialty Pharmacy. 201916 CitationsOPEN ACCESS
470M+ articles · 14-day free trial